Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) Interest & Investment Income (2016 - 2024)

Historic Interest & Investment Income for Bio Green Med Solution (BGMS) over the last 15 years, with Q1 2024 value amounting to $2000.0.

  • Bio Green Med Solution's Interest & Investment Income fell 9827.59% to $2000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $152000.0, marking a year-over-year decrease of 5279.5%. This contributed to the annual value of $12000.0 for FY2024, which is 9548.87% down from last year.
  • Bio Green Med Solution's Interest & Investment Income amounted to $2000.0 in Q1 2024, which was down 9827.59% from $23000.0 recorded in Q4 2023.
  • Over the past 5 years, Bio Green Med Solution's Interest & Investment Income peaked at $122000.0 during Q4 2022, and registered a low of $2000.0 during Q1 2024.
  • In the last 5 years, Bio Green Med Solution's Interest & Investment Income had a median value of $6000.0 in 2020 and averaged $31529.4.
  • As far as peak fluctuations go, Bio Green Med Solution's Interest & Investment Income soared by 295000.0% in 2022, and later plummeted by 9827.59% in 2024.
  • Bio Green Med Solution's Interest & Investment Income (Quarter) stood at $6000.0 in 2020, then crashed by 33.33% to $4000.0 in 2021, then soared by 2950.0% to $122000.0 in 2022, then plummeted by 81.15% to $23000.0 in 2023, then tumbled by 91.3% to $2000.0 in 2024.
  • Its Interest & Investment Income was $2000.0 in Q1 2024, compared to $23000.0 in Q4 2023 and $50000.0 in Q3 2023.